Variables | Glimepiride (n = 68) | Sitagliptin (n = 65) |
---|---|---|
Male/female (number, %) | 49/19 (72.1/27.9Â %) | 49/16 (75.4/24.6Â %) |
Age (year) | 64 (8) | 63 (9) |
BMI (kg/m2) | 24.7 (3.3) | 24.1 (3.8) |
Duration (year) | 6.0 (5.1) | 6.2 (6.0) |
HbA1c (NGSP, %) | 7.5 (0.5) | 7.4 (0.5) |
GA (%) | 19.5 (2.8) | 19.4 (2.7) |
eGFR (ml/min/1.73Â m2) | 74.9 (14.0) | 76.2 (17.1) |
ISI (l2/mmol pmol) | 16.2 (9.2, 24.0) | 16.3 (10.2, 22.0) |
Log transformed insulinogenic index (pmol/mmol) | 2.6 (2.1, 3.3) | 2.2 (1.9, 2.8) |
Starting dose (mg/day) | 0.25 (20.6Â %) | 25 (12.3Â %) |
0.5 (77.9Â %) | 50 (87.7Â %) | |
1.0 (1.5Â %) | 100 (0.0Â %) |